Skip to content
Screener

PTC Therapeutics PTCT Manufacturing Costs

Manufacturing Costs at other companies

Luxfer Holdings logo
Luxfer HoldingsLXFR
$8.6M+3.6%
Luxfer Holdings logo
Luxfer HoldingsLXFR
$200K-33.3%
Flex Ltd. logo
Flex Ltd.FLEX
$695M+9.1%
Flex Ltd. logo
Flex Ltd.FLEX
$758M+10.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$9.09M-39.2%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$829K+74.2%

Segments

By segment

See full
Life Science$9.09M-39.2%

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×—
P/S7×+4.7×

Profitability

See full
Gross margin96%—
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%—
Debt / equity372.3×—
Current ratio2.4×-1.5×